Latest Biotechnology, Pharmaceutical and Healthcare News - Page: 3 from PR Newswire

Fuse Science, Inc. European Distribution Partnership Expands Rapidly

MIAMI LAKES, Fla., May 24, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals is pleased to announce that its non-exclusive distribution partnership in Europe, based in Holland, has expand...

Biozoom Appoints Director Of Business Development/Sales And Corporate Secretary

KASSEL, Germany, May 24, 2013 /PRNewswire/ -- Biozoom (BIZM) announces the appointment of Tefa Dexter to the roles of Director of Business Development and Sales, and Corporate Secretary. Mr. Dexter assumed this responsibility as of January 21, 2013. "Tefa Dexter exemplifies the level of strategic thinking, business development expertise and general creative energy that Biozoom wants to see in...

InspireMD To Participate In Benchmark Investor Conference On May 30th

BOSTON and TEL AVIV, Israel, May 24, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, announced that Alan Milinazzo, the Company's President and Chief Executive Officer, and Craig Shore, the Company's Chief Financial Officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday May 30,...

For breast cancer patients seeking a natural reconstruction, HydraSolve® liposuction from Andrew Technologies offers the first FDA-cleared option to provide your own fat for transfer

IRVINE, Calif., May 24, 2013 /PRNewswire/ -- Andrew Technologies applauds the courage of actress Angelina Jolie and reporter Zoraida Sambolin of CNN to go public about their own personal experiences with breast cancer. This terrible disease has devastated the lives of many women and some men; and left many women with concerns about their perceived diminished femininity. Since HydraSolve®...

Allscripts Names New General Counsel, Adds Two Directors to Board

CHICAGO, May 24, 2013 /PRNewswire/ -- Allscripts announced today important additions to the company's senior leadership team and Board of Directors.  Brian Farley will join the company as Senior Vice President, General Counsel and Corporate Secretary effective May 28, 2013.  In addition, Allscripts added two new board members – Anita Pramoda and Michael Klayko –...

Transitions Optical and Visionworks® Collaborate with the American Diabetes Association to Continue Eye Health Education Efforts

PINELLAS PARK, Fla., May 24, 2013 /PRNewswire/ -- Transitions Optical, Inc., in partnership with Visionworks, continued to support the American Diabetes Association last week at the EXPO San Antonio event by educating and motivating consumers to visit an eye doctor regularly for comprehensive eye exams that help with the early detection and treatment of diabetes.  Outreach efforts focuse...

SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE

SAN DIEGO, May 24, 2013 /PRNewswire/ -- Senomyx, Inc. (NASDAQ: SNMX), a  company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients, announced today that David Linemeyer, Ph.D., the Company's Vice President, Biology and Gwen Rosenberg, Vice President, Investor Relations & Corporate Communications, will present an overview...

Medical Doctor Shares Life as a Caregiver for Her Father

HARBOR CITY, Calif., May 24, 2013 /PRNewswire/ -- A father with dementia.  A daughter with solid medical background and very personal fears. Would life turn out to be better and easier for them?  Their journey through nine years of challenging experiences, and the lessons learned which enabled them to remain loving and positive are all unveiled in Dr. Patricia H. Arnazzi's poignant...

International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma

LOS ANGELES, May 24, 2013 /PRNewswire/ -- An international roster of experts on malignant pleural mesothelioma (MPM) gathered on Saturday, May 18, in Santa Monica, Calif., to discuss their latest research findings on new lung-sparing therapies for MPM, a rare form of cancer that results from exposure to asbestos and commonly affects the pleura, the lining of the chest. Hosted by UCLA and the...

HCP Formulas Introduces Fibrenza™, a Natural, Ultra-Premium Systemic Enzyme Therapy Alternative Without Synthetic Chemicals

TEMPE, Ariz., May 24, 2013 /PRNewswire/ -- The newly released flagship enzyme blend, Fibrenza™, utilizes advanced technology in a time-release capsule that offers the benefits of enteric coatings, without the use of synthetic chemicals. (Photo:  http://photos.prnewswire.com/prnh/20130524/PH20296) Systemic enzyme use is at an all-time high, according to Heather Lewis, Brand...

Thousands of Nurses Attend Special Viewing of Acclaimed Nursing Documentary at AACN Conference

ALISO VIEJO, Calif., May 24, 2013 /PRNewswire/ -- A documentary about the complex world of nursing reached its largest audience to date when thousands of nurses attended a special screening May 22 during the annual conference of the American Association of Critical-Care Nurses (AACN). The documentary, "NURSES, If Florence Could See Us Now" was shown in Boston on Wednesday afternoon of AACN'...

Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

LOVELAND, Colo., May 24, 2013 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today that Dr. Robert Grieve, the Company's chairman and chief executive officer, and Jason Napolitano, executive vice president and chief financial officer, will present at the Second Annual Marcum MicroCap Con...

Stroke Is the Fourth Leading Cause of Death in U.S.

CENTENNIAL, Colo., May 24, 2013 /PRNewswire-USNewswire/ -- Wyatt David was starting his day as an elementary school teacher when he had sudden trouble seeing. It was a stroke. Luckily, he knew the signs and got to the hospital right away for treatment. David is one of 592 Faces of Stroke™ featured on stroke.org demonstrating the personal side of stroke and educating the public about importa...

Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences

SAN DIEGO, May 24, 2013 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the following investor conferences: Deutsche Bank Securities 38th Annual Health Care ConferencePresentation: May 30, 2013, at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time) at The Westin Boston Waterfront Hotel in Boston, Massa...

Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From California Institute for Regenerative Medicine (CIRM) to Develop ZFP Therapeutic® for Beta-thalassemia

RICHMOND, Calif., May 24, 2013 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million Strategic Partnership Award to develop a potentially curative ZFP Therapeutic for beta-thalassemia based on the application of its zinc finger nuclease (ZFN) gene-editing technology in hematopoie...

Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference

CHESTERBROOK, Pa., May 24, 2013 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Deutsche Bank Health Care Conference to be held May 29-30 at the Westin Boston Waterfront Hotel.  Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline...

It Takes A Global Village to End MS

NEW YORK, May 24, 2013 /PRNewswire-USNewswire/ -- Multiple sclerosis is a life altering disease that affects each person in a unique and different way.   More than 2.1 million people worldwide live with MS, which is why demonstrating the power and importance of the global MS movement is critical on World MS Day -- May 29. (Logo: http://photos.prnewswire.com/prnh/20090302/DC77093LOGO)...

Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements

NEW YORK, May 24, 2013 /PRNewswire/ -- In accordance with Rule 17.1 and Rule 2.9 of the Irish Takeover Rules and Rule 14e-1 of the United States Exchange Act, Echo Pharma Acquisition Limited ("Royalty Pharma") today announced acceptance levels its original offer for Elan Corporation (NYSE: ELN). Background On 2 May 2013, Echo Pharma Acquisition Limited ("Royalty Pharma") made an offer for the en...

China Biologic Comments on the Proposed Shanghai RAAS Transaction

BEIJING, May 24, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company has recently learned from a public announcement issued by Shanghai RAAS Blood Products Co., Ltd. ("Shanghai RAAS"), a public company listed on Shenzhen St...

Healthcare Trust of America, Inc. CEO Scott D. Peters Interviewed on TheStreet.com

SCOTTSDALE, Ariz., May 24, 2013 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced today that Chairman and CEO Scott D. Peters was interviewed by TheStreet.com. The interview focused on several key trends in the current medical office market including (i) the importance of internal asset management, (ii) the current development environment, (iii) the impact of the...

PBAC Approves XIFAXAN® (Rifaxamin α) 550 mg Cost Effectiveness in Australia

LONDON, May 24, 2013 /PRNewswire/ -- Norgine today announced that the Australian assessment body the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the use of XIFAXAN 550 mg in the prevention of the recurrence of hepatic encephalopathy (HE) where other treatments have failed or are contraindicated; a potentially life-threatening neuropsychiatric condition associated with liver...

Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines

BEIJING, May 24, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac, obtained the Certificate of Good Manufacturing Practices for Pharmaceutical Products (GMP Certificate) from the China State and Food Administration (CFDA) for its proprietary vacci...

Food Ingredients Industry Experts Share Their Key Insights Into the Future of Sugar and Sodium Reduction and Replacement

LONDON, May 24, 2013 /PRNewswire/ --  Leading industry experts have given their key insights into the future of sugar and sodium reduction and replacement, in a new industry report compiled by Fi Conferences. Speaker for the Reducing and Replacing Sugar and Sodium conference, Sam Waterfall, Senior Consultant at the Healthy Marketing Team, asserts that 'the next challenge is for food-tec...

Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany

LONDON, May 24, 2013 /PRNewswire/ -- The potential of the pulmonary route as a non-invasive administration for systemic delivery of therapeutic agents has been receiving undeniable attention with the recent advances of the inhalation drug delivery showing significant promise. The crucial formulation considerations for orally inhaled products together with those of a delivery device play a major r...

Heptares Augments Business Development Capabilities in Japan and Other Asian Territories

WELWYN GARDEN CITY, England and BOSTON, May 24, 2013 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR drug discovery and development company, is pleased to announce that it has engaged Mr Akira Usui as a Consultant to augment the Company's business development capabilities in Japan and other Asian territories. Mr Usui has more than 15 years of experience in business development, licensing...